Skip to main content
. 2015 Nov 10;65(1):53–62. doi: 10.1538/expanim.15-0062

Fig. 2.

Fig. 2.

Cancer induction in the BALB/c-congenic ANP32B-deficient mouse. (A) Kaplan-Meier survival curve of DMBA-treated BALB/c-congenic wild-type (+/+) and Anp32b-null (−/−) mice. Survival was determined by absence of defined humane endpoints. No genotype effect was evident at statistically significant levels. (B) Incidence of different tumor types in DMBA-treated mice. Mam, mammary; Ov, ovarian; Lym, lymphoid; Pul, pulmonary; CSCC, cutaneous squamous cell carcinoma. *, P<0.05 by Chi-square test.